Growth Metrics

Mesoblast (MESO) Return on Sales (2016 - 2023)

Historic Return on Sales for Mesoblast (MESO) over the last 10 years, with Q4 2024 value amounting to 2.68%.

  • Mesoblast's Return on Sales rose 131900.0% to 2.68% in Q4 2024 from the same period last year, while for Dec 2024 it was 2.68%, marking a year-over-year increase of 131900.0%. This contributed to the annual value of 5.94% for FY2025, which is 89600.0% up from last year.
  • Latest data reveals that Mesoblast reported Return on Sales of 2.68% as of Q4 2024, which was up 131900.0% from 6.51% recorded in Q2 2024.
  • In the past 5 years, Mesoblast's Return on Sales ranged from a high of 6.51% in Q2 2024 and a low of 28.95% during Q2 2020
  • Moreover, its 5-year median value for Return on Sales was 10.5% (2023), whereas its average is 9.88%.
  • Within the past 5 years, the most significant YoY rise in Mesoblast's Return on Sales was 266200bps (2020), while the steepest drop was -194900bps (2020).
  • Mesoblast's Return on Sales (Quarter) stood at 11.4% in 2020, then grew by 4bps to 10.95% in 2021, then dropped by -5bps to 11.54% in 2022, then grew by 9bps to 10.5% in 2023, then skyrocketed by 126bps to 2.68% in 2024.
  • Its last three reported values are 2.68% in Q4 2024, 6.51% for Q2 2024, and 10.5% during Q4 2023.